SERGIO RODARTE-ROJAS: Open Payments
NPI 1518172105 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 52 payments from 10 companies in 2025. Trend: 2023 $635 · 2024 $676 · 2025 $1,109
Food & beverage: $998Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $239 |
| E.R. Squibb & Sons, L.L.C. | 8 | $184 |
| Lundbeck LLC | 8 | $177 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Alkermes, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
| ABBVIE INC. | 1 | $19 |
Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, Auvelity, ARISTADA, ACTHAR, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
